EMCL RWE Tecartus
Laufzeit: 01.01.2023 - 31.12.2023
imported
Kurzfassung
Real world use of BrexuCel for patients with Mantle Cell Lymphoma in Germany
Laufzeit: 01.01.2023 - 31.12.2023
Real world use of BrexuCel for patients with Mantle Cell Lymphoma in Germany